Outcomes Among Drug Refractory Patients With Atrial Fibrillation (AF) and Concomitant Heart Failure With Preserved Ejection Fraction (HFpEF) Treated With Catheter Ablation Versus Antiarrhythmic Drugs
Among drug refractory AF patients with concomitant HFpEF, CA was shown to reduce the risk of recurrent arrhythmias as compared to AAD continuation.
Authors
- Saima Karim (ORCID: https://orcid.org/0000-0001-6252-2400)
- Rahul Khanna (ORCID: https://orcid.org/0000-0002-1342-9573)
- Alia Khaled (ORCID: https://orcid.org/0000-0003-3375-4813)
- Yiran Rong
- Syeda Atiqa Batul
- Abhishek J. Deshmukh
Institutions
- Johnson & Johnson (United States) (US)
- Mayo Clinic (US)
- Mayo Clinic in Arizona (US)
- Ohio Heart & Vascular Center (US)
- Mayo Clinic in Florida (US)
- Geisinger Commonwealth School of Medicine (US)
Publication Details
- Journal
- Journal of Cardiovascular Electrophysiology
- Published
- 2026-01-28
- DOI
- https://doi.org/10.1111/jce.70250
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00